Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Limitin: an interferon-like cytokine that preferentially influences B-lymphocyte precursors

Article Abstract:

Research is presented on an inferon-like cytokine called limitin and its ability to either arrest the growth of or kill lympho-hematopoietic cells. Issues discussed include limitin's inhibition of B lymphopoiesis, despite its inability to influence either myelopoiesis or erythropoiesis; and limitin's use of interferon receptors, which may indicate a previously unknown interferon prototype.

Author: Matsuzawa, Yuji, Oritani, Kenji, Medina, Kay L., Tomiyama, Yoshiaki, Ishikawa, Jun, Okajima, Yu, Ogawa, Megumu, Takahumi, Yokota, Aoyama, Keisuke, Takahashi, Isao, Kincade, Paul W.
Publisher: Nature America, Inc.
Publication Name: Nature Medicine
Subject: Health
ISSN: 1078-8956
Year: 2000
Japan, Analysis, Growth factors, B cells, Cytokines, Cell research, Cytological research, Interferon, Lymphocytes

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Endogenous microRNA regulation suppresses transgene expression in hematopoietic lineages and enables stable gene transfer

Article Abstract:

Regulation of small 21-23-nucleotide non-coding ribonucleic acids, (miRNA), which de-targets rather than targets gene expression and functions at the post-transcriptional level, might provide a unique means for overcoming the limitations of gene delivery systems. A study demonstrates that, by preventing transgene expression in hematopoietic lineages while permitting high levels of expression in nonhematopoietic cells, miRNA regulation could enable stable gene transfer in the absence of an immune response.

Author: Naldini, Luigi, Venneri, Mary Anna, Brown, Brian D., Zingale, Anna, Sergi, Lucia Sergi
Publisher: Nature America, Inc.
Publication Name: Nature Medicine
Subject: Health
ISSN: 1078-8956
Year: 2006
Science & research, Immune response

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Blasting away leukemia

Article Abstract:

CD44, a widely distributed glycoprotein, has been found to deliver a differentiation signal to leukemic blast cells that can perhaps be exploited for new therapies for acute myeloid leukemia. CD44-specific antibodies have been used successfully in experimental animals in spite of potential complications.

Author: Kincade, Paul W.
Publisher: Nature America, Inc.
Publication Name: Nature Medicine
Subject: Health
ISSN: 1078-8956
Year: 1999
Health aspects, Glycoproteins, Lymphocyte transformation, Cell differentiation, Acute leukemia, Promyelocytic, Acute myelocytic leukemia, Antibodies

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Research, United States, Physiological aspects, Gene expression, Hematopoietic stem cells
Similar abstracts:
  • Abstracts: Fas/FADD-mediated activation of a specific program of inflammatory gene expression in vascular smooth muscle cells
  • Abstracts: Rapid myeloerythroid repopulation after intrafemoral transplantation of NOD-SCID mice reveals a new class of human stem cells
  • Abstracts: Efficient retrovirus-mediated transfer of the multidrug resistance 1 gene into autologous human long-term repopulating hematopoietic stem cells
  • Abstracts: Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.